NCT07559136: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS9531 Injection in Adolescents With Obesity
- State
- Under way
- Phase
- Phase 1
- People
- 48 taking part
- Started
- 12 Jun 2026
- Primary completion
- Feb 2027
- Arms
- Treatment group A: HRS9531 injection or Placebo, Treatment group B: HRS9531 injection or Placebo, Treatment group C: HRS9531 injection or Placebo
- Results
- None posted
- 30 Apr 2026: Trial registered
- 12 Jun 2026: Trial started